Researchers at Weill Cornell Medicine have identified a key protein that induces the program to build specialized liver blood vessels. The discovery could lead to engineered replacement hepatic tissue to treat common liver diseases.
Back to News
Weill Cornell MedicineOffice of External Affairs
1300 York AvenueBox 314
New York, NY 10065
Phone: (646) 962-9476